Diagnostic methods for determining susceptibility to...

Details Diagnostic methods for determining susceptibility to... Diagnostic methods for determining susceptibility to...

G - Physics

01

N

G01N 33/50 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2399169

The present invention exploits the discovery that amounts of uracil and thymine metabolites, especially .beta.-aminoisobutyric acid, in various bodily fluids, especially urine, are correlated with the occurrence of epilepsy when compared to matched control subjects. Analytical and diagnostic protocols, including a novel high performance liquid chromatography system, for use in the invention are disclosed.

Affiliated with

Also associated with

Rating

Diagnostic methods for determining susceptibility to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic methods for determining susceptibility to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic methods for determining susceptibility to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1926690